Takeaim Leukemia- A Phase 1/2A Study Of The Irak4 Inhibitor Emavusertib (Ca-4948) As Monotherapy Or In Combination With Azacitidine Or Venetoclax In Relapsed/Refractory Aml Or Mds
Azacitidine;Emavusertib;Venetoclax
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Takeaim Leukemia- A Phase 1/2A Study Of The Irak4 Inhibitor Emavusertib (Ca-4948) As Monotherapy Or In Combination With Azacitidine Or Venetoclax In Relapsed/Refractory Aml Or Mds ### Output: Azacitidine;Emavusertib;Venetoclax